Nexalin Technology (NXL) Short Interest Ratio & Short Volume

Short interest is the volume of Nexalin Technology shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 23,400 shares of NXL short. 0.17% of Nexalin Technology's shares are currently sold short. Learn More on Nexalin Technology's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.17% of Nexalin Technology's floating shares are currently sold short.

Nexalin Technology saw a drop in short interest in July. As of July 31st, there was short interest totaling 23,400 shares, a drop of 65.7% from the previous total of 68,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Nexalin Technology currently has issued a total of 17,420,000 shares. Some of Nexalin Technology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nexalin Technology currently has a public float of 14,060,000 shares.

0.17% of Nexalin Technology's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Nexalin Technology: Sensus Healthcare, Inc. (6.10%), Spectral AI, Inc. (5.16%), IceCure Medical Ltd. (5.07%), Fractyl Health, Inc. (9.58%), Daxor Corporation (0.30%), Alpha Pro Tech, Ltd. (0.57%), Milestone Scientific Inc. (0.22%), Zynex Inc. (19.33%), SurgePays, Inc. (1.05%), Nephros Inc. (0.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

Short selling NXL is an investing strategy that aims to generate trading profit from Nexalin Technology as its price is falling. NXL shares are trading up $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nexalin Technology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NXL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXL, twice per month. The most recent reporting period available is July, 31 2025.